Predictive Oncology Inc.
POAI
$6.00
$0.458.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -77.65M | -2.07M | -2.44M | -2.17M | -3.09M |
| Total Depreciation and Amortization | 174.60K | 170.30K | 166.10K | 573.60K | 158.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 74.88M | -547.50K | 387.00K | -14.00K | 338.10K |
| Change in Net Operating Assets | 947.60K | -876.10K | 1.13M | -538.50K | -574.70K |
| Cash from Operations | -1.65M | -3.32M | -756.30K | -2.15M | -3.17M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 625.00K | 0.00 | 32.00K |
| Cash from Investing | 0.00 | 0.00 | 625.00K | 0.00 | 32.00K |
| Total Debt Issued | 0.00 | 264.00K | -- | 0.00 | 0.00 |
| Total Debt Repaid | -76.70K | -- | -- | -195.80K | -79.30K |
| Issuance of Common Stock | 1.44M | 586.00K | 2.58M | 0.00 | 1.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -38.10K | -123.10K | -79.70K | 0.00 | -297.10K |
| Cash from Financing | 1.33M | 726.90K | 2.50M | -195.80K | 888.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -324.40K | -2.60M | 2.37M | -2.34M | -2.25M |